Genetics of alzheimer's disease: An insight into presenilins and apolipoprotein e instigated neurodegeneration

International Journal of Neuroscience

Volumn 121, Issue 5, 2011, Pages 229-236

  Obulesu, M ^a   Somashekhar, R ^b   Venu, R ^b  

^a RAYALASEEMA UNIVERSITY   (India)

^b Capital College   (India)

Author keywords

Alzheimer's disease; apolipoprotein E; presenilin 1; presenilin 2

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CYSTATIN C; PRESENILIN; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; ARTICLE; FAMILIAL DISEASE; GENE MUTATION; HUMAN; NERVE DEGENERATION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APOLIPOPROTEINS E; DISEASE MODELS, ANIMAL; HUMANS; LIPID METABOLISM; NEURODEGENERATIVE DISEASES; PRESENILIN-1;

EID: 79955866845     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.551432     Document Type: Article

References (88)

1. Abdul, H. M., Sultana, R., St Clair, D. K., Markesbery, W. R., & Butterfeld, D. A. (2008). Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. Free Radical Biology and Medicine, 45(10), 1420-1425.
2. Albrecht, S., Bogdanovic, N., Ghetti, B., Winblad, B., & LeBlanc, A. C. (2009). Caspase-6 activation in familial Alzheimer disease brains carrying amyloid precursor protein or presenilin I or pre-senilin II mutations. Journal of Neuropatholology and Experimental Neurology, 68(12), 1282-1293.
3. Bales, K. R. (2010). Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer's disease. Neuropharmacology, 59(4-5), 295-302.
4. Bales, K. R., Liu, F., Koger, D., Wu, S., Mabry, T., Christie, M., et al. (2008). Apolipoprotein E-isoform dependent decrease in brain brain ï-amyloid following treatment of PDAPP transgenic mice with a LXR agonist.Society of Neuroscience Abstracts, 45, 14.
5. Bales, K. R., Liu, F., Wu, S., Lin, S., Koger, K., DeLong, C, et al. (2009). Human APOE isoform-dependent effects on brain beta amyloid levels in PDAPP transgenic mice. The Journal of Neuroscience, 29(21), 6771-6779.
6. Bales, K. R., Verina, T., Cummins, D. J., Du, Y, Dodel, R. C, Saura, J., et al. (1999). Apolipoprotein E is essential for amyloid deposition in the APP (V717F) transgenic mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 96(26), 15233-15238. (Pubitemid 30019795)
7. Bales, K. R., Verina, T., Dodel, R. C, Du, Y, Altsteil, L., Bender, M., et al. (1997). Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nature Genetics, 17(3), 263-264.
8. Bergmans, B. A., & De Strooper, B. (2010). Gamma-secretases: From cell biology to therapeutic strategies. The Lancet Neurology, 9(2), 215-226.
9. Bettens, K., Sleegers, K., & Van Broeckhoven, C. (2010). Current status on Alzheimer disease molecular genetics: From past, to present, to future. Human Molecular Genetics, 19(R1), R4-R11.
10. Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W, & Taylor, J. M. (1995). Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmylinating glia of the peripheral nervous system. The Journal of Clinical Investigation, 76(4), 1501-1513.
11. Bruno, E., Quattrocchi, G., Nicoletti, A., Le Pira, F., Maci, T., Mos-tile, G., et al. (2010). Lack of interaction between LRP1 and A2M polymorphisms for the risk of Alzheimer disease. Neuroscience Letters, 482(2), 112-116.
12. Cervantes, S., Saura, C. A., Pomares, E., Gonzalez-Duarte, R., & Marfany, G. (2004). Functional implications of the presenilin dimerization: Reconstitution of y-secretase activity by assembly of a catalytic site at the dimer interface of two catalyti-cally inactive presenilins. Journal of Biological Chemistry, 279(35), 36519-36529. (Pubitemid 39128993)
13. Corder, E. H., Saunders, A. M., Risch, N. J., Strittmater, W J., Schmechel, D. E., Gaskell, P. C, Jr., et al. (1994). Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics, 7(2), 180-184. (Pubitemid 24174658)
14. De Gasperi, R., Sosa, M. A., Dracheva, S., & Elder, G. A. (2010). Presenilin-1 regulates induction of hypoxia inducible factor1es: Altered activation by a mutation associated with familial Alzheimer's disease. Molecular Neurodegeneration, 5, 38.
15. De Strooper, B. (2003). Aph-1, pen-2, and nicastrin with presenilin generate an active y-secretase complex. Neuron, 38(1), 9-12. (Pubitemid 36423348)
16. Elder, G. A., Gama Sosa, M. A., De Gasperi, R., Dickstein, D. L., & Hof, P. R. (2010). Presenilin transgenic mice as models of Alzheimer's disease. Brain Structure and Function, 214(2-3), 127-143.
17. Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S. Y, Dence, C. S., Shah, A. R., et al. (2005). Inverse relation between in vivo amyloid imaging load and cerebrospinal fuid A/Ï42 in humans. Annals of Neurology, 59(3), 512-519. (Pubitemid 43358072)
18. Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W A., Mayeux, R., et al. (1997). Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. Ameta-analysis. The Journal of the American Medical Association, 278(16), 1349-1356. (Pubitemid 27449696)
19. Galimberti, D., & Scarpini, E. (2010). Genetics and biology of Alzheimer's disease and frontotemporal lobar degeneration. International Journal of Clinical and Experimental Medicine, 3(2), 129-143.
20. Gama Sosa, M. A., Gasperi, R. D., Rocher, A. B., Wang, A. C., Janssen, W. G., Flores, T., et al. (2010). Age-related vascular pathology in transgenic mice expressing presenilin 1-associated familial Alzheimer's disease mutations. American Journal of Pathology, 176(1), 353-368.
21. Ghidoni, R., Benussi, L., Paterlini, A., Missale, C., Usardi, A., Rossi, R., et al. (2007). Presenilin 2 mutations alter cystatin C traf-fcking in mouse primary neurons. Neurobiology of Aging, 28(3), 371-376. (Pubitemid 46177387)
22. Ghidoni, R., Paterlini, A., Albertini, V., Glionna, M., Monti, E., Schi-affonati, L., et al. (2009). Cystatin C is released in association with exosomes: A new tool of neuronal communication which is unbalanced in Alzheimer's disease. Neurobiology of Aging, in press.
23. Green, K. N., Demuro, A., Akbari, Y., Hitt, B. D., Smith, I. F., Parker, I., et al. (2008). SERCA pump activity is physiologically regulated by presenilin and regulates amyloid beta production. Journal of Cell Biology, 181(7), 1107-1116. (Pubitemid 351915486)
24. Grimmer, T., Tholen, S., Yousef, B. H., Alexopoulos, P., Forschler, A., Forstl, H., et al. (2010). Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer's disease. Biological Psychiatry, 68(10), 879-884.
25. Guyant-Marechal, L., Campion, D., & Hannequin, D. (2009). Alzheimer disease: Autosomal dominant forms. Revue Neu-rologique, (Par is), 165(3), 223-231.
26. Hardy, J. (1992). Framing β-amyloid. Nature Genetics, 1(4), 233-234.
27. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., et al. (2009). Genome-wide association study identifes variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics, 41(10), 1088-1093.
28. Hashimoto, Y., Ito, Y., Arakawa, E., Kita, Y., Terashita, K., Ni-ikura, T., et al. (2002). Neurotoxic mechanisms triggered by Alzheimer's disease-linked mutant M146L presenilin 1: Involvement of NO synthase via a novel pertussis toxin target. Journal of Neurochemistry, 80(3), 426-437. (Pubitemid 36383026)
29. Hashimoto, Y., Niikura, T., Ito, Y., & Nishimoto, I. (2000). Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. The Journal of Biological Chemistry, 275(44), 34541-34551.
30. Hashimoto, Y., Niikura, T., Ito, Y., Sudo, H., Hata, M., Arakawa, E., et al. (2001). Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. Journal of Neuroscience, 21(23), 9235-9245. (Pubitemid 33096867)
31. Holtzman, D. M., Bales, K. R., Tenkova, T., Fagan, A. M., Parsadanian, M., Satorius, L. J., et al. (2000). Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences, USA, 97(6), 2892-2897. (Pubitemid 30159268)
32. Hyman, B. T., West, H. L., Rebeck, G. W., Buldyrev, S. V., Mantegna, R. N., Ukleia, M., et al. (1995). Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proceedings of the National Academy of Sciences, USA, 92(8), 3586-3590.
33. Ikeuchi, T., Kaneko, H., Miyashita, A., Nozaki, H., Kasuga, K., Tsukie, T., et al. (2008). Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Dementia and Geriatric and Cognitive Disorders, 26(1), 43-49.
34. Irizarry, M. C., Rebeck, G. W., Cheung, B., Bales, K. R., Paul, S. M., Holtzman, D. M., et al. (2000). Modulation of Aβ deposition in APP transgenic mice by an apolipoprotein E null background. Annals of the New York Academy of Sciences, 920, 171-178. (Pubitemid 32056566)
35. Ito, Y., Ishii, A., Passmore, A. P., & McIlroy, S. P. (2007). Analysis of alteration of p75NTR processing and signalling by PS2 mutation and gamma-secretase inhibition. Neurobiology of Disease, 27(3), 258-264. (Pubitemid 47334956)
36. Iurescia, S., Fioretti, D., Mangialasche, F., & Rinaldi, M. (2010). The pathological cross talk between apolipoprotein E and amyloid-beta peptide in Alzheimer's disease: Emerging gene-based therapeutic approaches. Journal of Alzheimers Disease, 21(1), 35-48.
37. Kecmanovic, M., Dobricic, V., Dimitrijevic, R., Keckarevic, D., Savic-Pavicevic, D., Keckarevic-Markovic, M., et al. (2010). Schizophrenia and apolipoprotein E gene polymorphism in Serbian population. International Journal of Neuroscience, 120(7), 502-506.
38. Kim, K. S., Wegiel, J., Sapienza, V., Chen, J., Hong, H., & Wisniewski, H. M. (1997). Immunoreactivity of presenilin-1 in human, rat and mouse brain. Brain Research, 757(1), 159-163. (Pubitemid 27244634)
39. Koo, E. H., & Kopan, R. (2004). Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration. Nature Medicine, (10 Suppl), S26-S33. (Pubitemid 38901864)
40. Kumar, V. B., Franko, M., Banks, W. A., Kasinadhuni, P., Farr, S. A., Vyas, K., et al. (2009). Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. Journal of Experimental Biology, 212(4), 494-498.
41. Lah, J. J., Heilman, C. J., Nash, N. R., Rees, H. D., Yi, H., Counts, S. E., et al. (1997). Light and electron microscopic localization of presenilin1 in primate brain. The Journal of Neuroscience, 17(6), 1971-1980. (Pubitemid 27106756)
42. Lambert, J. C., & Amouyel, P. (2007). Genetic heterogeneity of Alzheimer's disease: Complexity and advances.Psychoneuroendocrinology, 32(Suppl 1), S62-S70. (Pubitemid 47211638)
43. Lambert, J. C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., et al. (2009). Genome-wide association study identifes variants at CLU and CR1 associated with Alzheimer's disease. Nature Genetics, 41(10), 1094-1099.
44. Langbaum, J. B., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., et al. (2010). Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele. Archives of Neurology, 67(4), 462-468.
45. Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, H., et al. (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science, 269(5226), 973-977.
46. Liang, G., Wang, Q., Li, Y., Kang, B., Eckenhoff, M. F., Eckenhoff, R. G., et al. (2008). A presenilin-1 mutation renders neurons vulnerable to isofurane toxicity. Anesthesia and Analgesia, 106(2), 492-500. (Pubitemid 351156673)
47. Liang, P., Pan, Y. X., Zhao, X. M., Du, H. Z., & Zhang, J. M. (2005). Study on expression of PS1 in APP-PS1 double gene stably trans-fected cell lines and its relation to gamma-secretase. Zhonghua Bing Li Xue Za Zhi, 34(5), 297-301.
48. Mauch, D. H., Nagler, K., Schumacher, S., Goritz, C., Muller, E. C., Otto, A., et al. (2001). CNS synaptogenesis promoted by glia-derived cholesterol. Science, 294(5545), 1354-1357. (Pubitemid 33063104)
49. Mi, W., Jung, S. S., Yu, H., Schmidt, S. D., Nixon, R. A., Mathews, P. M., et al. (2009). Complexes of amyloid-β and cystatin C in the human central nervous system. Journal of Alzheimers Disease, 18(2), 273-280.
50. Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., et al. (2009). APOE predicts Aβ but not Tau Alzheimer's pathology in cognitively normal aging. Annals of Neurology, 67(1), 122-131.
51. Muller, T., Meyer, H. E., Egensperger, R., & Marcus, K. (2008). The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer's disease. Progress in Neurobiology, 85(4), 393-406.
52. Munter, L. M., Botev, A., Richter, L., Hildebrand, P. W., Althoff, V., Weise, C., et al. (2010). Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif. Journal of Biological Chemistry, 285(28), 21636-21643.
53. Nahalkova, J., Volkmann, I., Aoki, M., Winblad, B., Bogdanovic, N., Tjernberg, L. O., et al. (2010). CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular traffcking is affected by presenilin-2. Neurochemistry International, 56(1), 67-76.
54. Niikura, T., Yamada, M., Chiba, T., Aiso, S., Matsuoka, M., & Nishi-moto, I. (2004). Characterization of V642I-AbetaPP-induced cytotoxicity in primary neurons. Journal of Neuroscience Research, 77(1), 54-62. (Pubitemid 38850055)
55. Nikisch, G., Wiedemann, G., Kiessling, B., & Hertel, A. (2008). Familial Alzheimer's disease with presenilin 2 N141I mutation. A case report. Fortschritte der Neurologie-Psychiatrie, 76(10), 606-609.
56. Nizzari, M., Venezia, V., Repetto, E., Caorsi, V., Magrassi, R., Gagliani, M. C., et al. (2007). Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1, 2 signaling. The Journal of Biological Chemistry, 282(18), 13833-13844. (Pubitemid 47100564)
57. Obulesu, M., & Rao, D. M. (2010a). DNA damage and impairment of DNA repair in Alzheimer's Disease. The International Journal of Neuroscience, 120(6), 397-403.
58. Obulesu, M., & Rao, D. M. (2010b). Animal models of Alzheimer's disease: An understanding of pathology and therapeutic avenues. The International Journal of Neuroscience, 120(8), 531-537.
59. Obulesu, M., Rao, D. M., & Shamasundar, N. M. (2009). Studies on genomic DNA stability in aluminium maltolate treated aged New Zealand rabbit: Relevance to the Alzheimer's animal model. Journal of Clinical and Medicinal Research, 1(4), 212-218.
60. Odero, G. L., Oikawa, K., Glazner, K. A., Schapansky, J., Grossman, D., Thiessen, J. D., et al. (2010). Evidence for the involvement of calbindin D28k in the presenilin 1 model of Alzheimer's disease. Neuroscience, 169(1), 532-543.
61. 2+ homeostasis in type I cortical astrocytes by hypoxia: Evidence for association with Alzheimer's disease. Biological Chemistry, 385(3-4), 285-289. (Pubitemid 38679074)
62. Placanica, L., Tarassishin, L., Yang, G., Peethumnongsin, E., Kim, S. H., Zheng, H., et al. (2009). Pen2 and presenilin-1 modulate the dynamic equilibrium of presenilin-1 and presenilin-2 gamma-secretase complexes. The Journal of Biological Chemistry, 284(5), 2967-2977.
63. Prince, J. A., Zetterberg, H., Andreasen, N., Marcusson, J., & Blennow, K. (2004). APOE 34 allele is associated with reduced cerebrospinal fuid levels of Aβ 42. Neurology, 62(11), 2116-2118. (Pubitemid 38738236)
64. Riddell, D. R., Zhou, H., Comery, T. A., Kouranova, E., Lo, C. F., Warwick, H. K., et al. (2007). The LXR agonist T0901317 selectively lowers hippocampal Ab42 and improves memory in the Tg2576 mouse model of Alzheimer's disease. Molecular and Cellular Neuroscience, 34(4), 621-628. (Pubitemid 46483091)
65. Rocchi, A., Pellegrini, S., Siciliano, G., & Murri, L. (2003). Causative and susceptibility genes for Alzheimer's disease: A review. Brain Research Bulletin, 61(1), 1-24. (Pubitemid 36682979)
66. Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y, et al. (1995). Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 376(6543), 775-778.
67. Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., et al. (1993). Association of apolipoprotein allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43(8), 1467-1472. (Pubitemid 23230526)
68. Saura, C. A. (2010). Presenilin/y-secretase and infammation. Frontiers of Aging Neuroscience, 2, 16.
69. Saura, C. A., Tomita, T., Davenport, F., Harris, C. L., Iwatsubo, T., & Thinakaran, G. (1999). Evidence that intramolecular associations between presenilin domains are obligatory for endopro-teolytic processing. The Journal of Biological Chemistry, 274(20), 13818-13823.
70. Schmechel, D. E., Saunders, A. M., Strittmater, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., et al. (1993). Increased amyloid beta peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proceedings of the National Academy of Sciences, USA, 90(20), 9649-9653. (Pubitemid 23315843)
71. Schon, E. A., & Area-Gomez, E. (2010). Is Alzheimer's disease a disorder of mitochondria-associated membranes? Journal of Alzheimers Disease, 20(Suppl 2), S281-S292.
72. Selkoe, D. J. (2002). Alzheimer's disease is a synaptic failure. Science, 298(5594), 789-791. (Pubitemid 35231524)
73. Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., et al. (1995). Cloning of novel gene bearing mis-sense mutations in early onset familial Alzheimer's disease. Nature, 375(6534), 754-760.
74. Strittmatter, W. J., & Roses, A. D. (1995). Apolipoprotein E and Alzheimer disease. Proceedings of the National Academy of Sciences, USA, 92(11), 4725-4727.
75. Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., et al. (1993). Apolipoprotein E: High-avidity binding to ß amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proceedings of the National Academy of Sciences, USA, 90(5), 1977-1981. (Pubitemid 23069980)
76. Takasugi, N., Tomita, T., Hayashi, I., Tsuruoka, M., Niimura, M., Takahashi, Y, et al. (2003). The role of presenilin cofactors in the y-secretase complex. Nature, 422(6930), 438-441. (Pubitemid 36411397)
77. Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., et al. (1996). Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron, 17(1), 181-190. (Pubitemid 26251602)
78. Tirado, V., Motta, M., Aguirre-Acevedo, D. C, Pineda, D. A., & Lopera, F. (2008). Analysis of intrusive errors in a memory test as possible pre-clinical marker of familial Alzheimer disease, in E280A presenilin-1 mutation carrier. Revista de Neurologia, 47(6), 290-294.
79. Veeraraghavalu, K., Choi, S. H., & Sisodia, S. S. (2010). Expression of familial Alzheimer's disease-linked human presenilin 1 variants impair enrichment-induced adult hippocampal neurogene-sis. Neurodegenerative Diseases, 7(1-3), 46-49.
80. Wan, J., Fu, A. K., Ip, F. C, Ng, H. K., Hugon, J., Page, G., et al. (2010). Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: Implications in Alzheimer's disease. The Journal of Neuroscience, 30(20), 6873-6881.
81. Wanngren, J., Franberg, J., Svensson, A. I., Laudon, H., Olsson, F, Winblad, B., et al. (2010). The large hydrophilic loop of presenilin 1 is important for regulating gamma-secretase complex assembly and dictating the amyloid beta peptide (Abeta) profle without affecting Notch processing. The Journal of Biological Chemistry, 285(12), 8527-8536.
82. Weggen, S., Diehlmann, A., Buslei, R., Beyreuther, K., & Bayer, T. A. (1998). Prominent expression of presenilin-1 in senile plaques and reactive astrocytes in Alzheimer's disease brain. Neuroreport, 9(14), 3279-3283. (Pubitemid 28522349)
83. Weisgraber, K. H. (1994). Apolipoprotein E: Structure function relationships. Advances in Protein Chemistry, 45, 249-302.
84. Williamson, J., Goldman, J., & Marder, K. S. (2009). Genetic aspects of Alzheimer disease. Neurologist, 15(2), 80-86.
85. Yagi, T., Giallourakis, C., Mohanty, S., Scheidig, C., Shen, J., Zheng, H., et al. (2008). Defective signal transduction in B lymphocytes lacking presenilin proteins. Proceedings of the National Academy of Sciences, USA, 105(3), 979-984. (Pubitemid 351282067)
86. Yin, Y. I., Bassit, B., Zhu, L., Yang, X., Wang, C., & Li, Y. M. (2007). {gamma}-secretase substrate concentration modulates the Abeta42/Abeta40 ratio: Implications for Alzheimer's disease. The Journal of Biological Chemistry, 282(32), 23639-23644. (Pubitemid 47311934)
87. Zhu, M., Gu, F., Shi, J., Hu, J., Hu, Y., & Zhao, Z. (2008). Increased oxidative stress and astrogliosis responses in conditional double-knockout mice of Alzheimer-like presenilin-1 and presenilin-2. Free Radical Biology and Medicine, 45(10), 1493-1499.
88. Zou, K., Hosono, T., Nakamura, T., Shiraishi, H., Maeda, T., Ko-mano, H., et al. (2008). Novel role of presenilins in maturation and transport of integrin beta 1. Biochemistry, 47(11), 3370-3378. (Pubitemid 351399225)